Traduction de «Essai sous charge constante » (Français → Anglais) :

115. Notes, nevertheless, the serious and contested allegations against both the Moroccan and Polisario administrations; recalls also the UN Secretary-General’s recent emphasis on ‘independent, impartial, comprehensive and sustained monitoring of the human rights situation in both Western Sahara and the camps’; notes, in this connection, that the UN did not upgrade the mandate of MINURSO in April 2013 to incorporate a human rights dimension; encourages the UN to do so, or else to establish a new, permanent, impartial human rights body for the purpose of supervising and reporting on the overall situation of human rights, and investigat ...[+++]ing individual complaints; calls on such a body to encompass the Moroccan-controlled section of Western Sahara, the Tindouf camps, and other territory controlled by the Polisario Front;

(Return tabled) Question No. 425 Ms. Kirsty Duncan: With respect to the current pandemic of new influenza A (H1N1): (a) who is at the top of the pandemic organizational chart for the country; (b) what gaps still exist in the government’s overarching plan, recognizing that it is an ever-evolving plan, and by what date will identified gaps be addressed; (c) what money remains from the $400 million contained in the budget of 2006 as ‘to be set aside as a contingency to be accessed on an as-needed basis’; (d) what funds have been spent ...[+++] since the start of the pandemic in Canada to address response, specifically, (i) what government departments have tested their pandemic plan, (ii) what departments operationalized their plans or part of their plans in the spring, and updated their plans since the lessons learned from the spring; (e) should there be an election, what is the pandemic preparedness plan for Elections Canada, both to protect the health and well-being of its employees and Canadians; (f) what are the outstanding issues among medical personnel in terms of preparedness, and how are these issues being addressed; (g) what was the process for monitoring swine herds prior to April 24, 2009, and how has it increased since that date; (h) what is the purpose behind the absence of a Canadian notifiable swine influenza surveillance system; (i) what is known of the clinical spectrum of the disease at this time, and what are the possible long-term impacts on lungs, and other organs, and potential long-term costs to the healthcare system; (j) by what date are provincial and territorial vaccine distribution plans to be in place, what oversight exists to ensure they are in place, and will they be made public; (k) what contingency plans are being put in place should Canadian distributors run out of stock of N95 masks; (l) will there be a compensation package should there be challenges with the vaccine; (m) what recommendations are being made to those with chronic con ...

What I am calling for, however, along with Senator Dallaire, is for the contributions of military equipment and training staff, which the Canadian military does have on hand, as well as our excellent Canadian diplomatic leadership on the issue to create coherent and consistent international pressure on the Government of Sudan.

a new expert committee, within the European Medicines Agency to assess and agree companies’ testing plans; a requirement at the time of marketing authorisation applications for data on the use of the medicine in children (plus a system of waivers from this requirement for medicines unlikely to benefit children and a system of deferrals to ensure medicines are tested in children only when it is safe to do so and to ensure the requirements do not delay the authorisation of medicines for adults); a reward for studying medicines for children of 6-months extension to the supplementary protection certificate - in effect, six-month patent extension; for off-patent medicines, ten-years of data protection for new studies awarded via a Paediatri ...[+++]c Use Marketing Authorisation (P.U.M.A); increased safety monitoring for children’s medicines and compulsory submission by industry of existing studies in children; an EU inventory of the therapeutic needs of children and an EU network of investigators and trial centres to conduct the studies required; a system of free scientific advice for the industry, provided by the European Medicines Agency.

The main duties of this task force are to develop an internationally harmonised testing strategy and to coordinate and oversee the work of different sub-groups charged with developing new test guidelines, or revise existing ones to assess the potential endocrine-disrupting properties of chemicals.

The main duties of this task force are to develop an internationally harmonised testing strategy and to coordinate and oversee the work of different sub-groups charged with developing new test guidelines, or revise existing ones to assess the potential endocrine-disrupting properties of chemicals.